# Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study

> **NCT02414438** · NA · COMPLETED · sponsor: **Qure Healthcare, LLC** · enrollment: 217 (actual)

## Conditions studied

- Intellectual Disability
- Developmental Delay

## Interventions

- **OTHER:** FirstStepDX PLUS and NextStepDX PLUS Webinar
- **OTHER:** FirstStepDX PLUS and NextStepDX PLUS Test Results

## Key facts

- **NCT ID:** NCT02414438
- **Lead sponsor:** Qure Healthcare, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02414438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02414438, "Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02414438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*